All In MedTech

Device Trial Radar · NCT00667511

Comparison of Nocturnal Hemodialysis (NHD) and Short Daily Hemodialysis (DHD) With the NxStage® System One™

Last checked: Nov 21, 2026Latest source record: Jan 14, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

58

Actual

Start

Apr 2008

Primary completion

May 2014

Study completion May 2014

Sponsor

Lead sponsor
NxStage MedicalAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Apr 28, 2008

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Crossover
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine whether or not nocturnal hemodialysis is equivalent to short daily hemodialysis on a per treatment basis, using the NxStage System One in the home setting.

Conditions

  • Kidney Failure, Chronic
  • End-Stage Renal Disease

Interventions

  • NxStage System OneDevice

    Comparison of Nocturnal (NHD) and Short Daily Hemodialysis (DHD) with the NxStage System One

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Primary Efficacy: Compare the Ability to Deliver the Clinically Prescribed Amount of Therapy in the Nocturnal Hemodialysis and Short Daily Hemodialysis Phases.Time frame: Study Week 20

1 more outcomes with a free account

Locations

9 sites in 1 country. Site status is shown where the registry gives one.

  • Satellite Healthcare/Wellbound

    San Jose, California

8 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.